Moreover, the gut-selective dose of sitagliptin was unable to lower TG excursion in HFD-fed Dpp4 EC+/+ and Dpp4 EC/ mice, before and after BMT, despite an approximately 20% reduction in plasma DPP-4 activity and an increase in active GLP-1 (Figure 7)
Tirzepatide also causes considerable weight loss, about 10-15% of body weight over 6 months
Be sure to store it out of reach of children and pets
It's a targeted intervention designed to protect what matters most during weight management: the metabolically active muscle that keeps metabolism humming and the dense, strong bones that provide structural integrity for decades to come
Circulating levels of active GLP-1 were increased approximately 4-fold in response to 10 mg/kg sitagliptin (Figure 1C)
Semaglutide dosing follows a gradual escalation protocol, starting at 0.25 mg and increasing every four weeks until reaching the maximum therapeutic dose of 2.4 mg per week